• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化还原状态生物标志物在ST段抬高型心肌梗死或非ST段抬高型心肌梗死患者中的预后价值:一项前瞻性病例对照临床研究

Prognostic Value of Redox Status Biomarkers in Patients Presenting with STEMI or Non-STEMI: A Prospective Case-Control Clinical Study.

作者信息

Savovic Zorica, Pindovic Bozidar, Nikolic Maja, Simic Ivan, Davidovic Goran, Ignjatovic Vladimir, Vuckovic Jelena, Zornic Nenad, Nikolic Turnic Tamara, Zivkovic Vladimir, Srejovic Ivan, Bolevich Sergej, Jakovljevic Vladimir, Iric Cupic Violeta

机构信息

Department of Internal Medicine, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.

Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.

出版信息

J Pers Med. 2023 Jun 26;13(7):1050. doi: 10.3390/jpm13071050.

DOI:10.3390/jpm13071050
PMID:37511663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10381258/
Abstract

(1) Background: The aim of our study was to determine the role of oxidative stress (OS) during early evaluation of acute ST-elevated myocardial infarction (STEMI) and non-ST-elevated myocardial infarction (NSTEMI) patients in order to define the role of redox balance in profiling the development of myocardial infarction (MI). (2) Methods: This prospective observational case-control study included 40 consecutive STEMI and 39 NSTEMI patients hospitalized in the coronary care unit of the cardiology clinic at the Kragujevac Clinical Center, Serbia, between 1 January 2016 and 1 January 2017. Blood samples were collected from all patients for measuring cardio-specific enzymes at admission and 12 h after admission to evaluate systemic oxidative stress biomarkers and the activity of antioxidant enzymes. (3) Results: In this study, participants were predominately female (52%), with a mean age of 56.17 ± 1.22 years old in the STEMI group and 69.17 ± 3.65 in the non-STEMI group. According to the Killip classification, the majority of patients (>50%) were at the second and third level. We confirmed the elevation of superoxide anion radicals in the non-STEMI group 6 h after admission in comparison with the STEMI and CTRL groups, but levels had decreased 12 h after admission. Levels of hydrogen peroxide were statistically significantly increased in the NSTEMI group. A positive correlation of superoxide anion radicals and levels of troponin I at admission was observed (r = 0.955; = 0.045), as well as an inverse correlation between reduced glutathione and levels of NT-pBNP measured 6 h after admission (r = -0.973; = 0.027). (4) Conclusions: We confirmed that superoxide anion radicals and reduced glutathione observed together with hs-troponin I at admission and NT-pBNP during hospital treatment could be predictors of ST evolution.

摘要

(1) 背景:我们研究的目的是确定氧化应激(OS)在急性ST段抬高型心肌梗死(STEMI)和非ST段抬高型心肌梗死(NSTEMI)患者早期评估中的作用,以明确氧化还原平衡在心肌梗死(MI)发展过程中的作用。(2) 方法:这项前瞻性观察性病例对照研究纳入了2016年1月1日至2017年1月1日期间在塞尔维亚克拉古耶瓦茨临床中心心脏病科冠心病监护病房住院的40例连续STEMI患者和39例NSTEMI患者。在入院时和入院后12小时采集所有患者的血样,以测量心脏特异性酶,评估全身氧化应激生物标志物和抗氧化酶的活性。(3) 结果:在本研究中,参与者以女性为主(52%),STEMI组的平均年龄为56.17±1.22岁,非STEMI组为69.17±3.65岁。根据Killip分级,大多数患者(>50%)处于二级和三级。我们证实,与STEMI组和对照组相比,非STEMI组入院后6小时超氧阴离子自由基升高,但入院后12小时水平下降。NSTEMI组过氧化氢水平在统计学上显著升高。观察到入院时超氧阴离子自由基与肌钙蛋白I水平呈正相关(r = 0.955;P = 0.045),以及入院后6小时测量的还原型谷胱甘肽与NT - pBNP水平呈负相关(r = -0.973;P = 0.027)。(4) 结论:我们证实,入院时与高敏肌钙蛋白I一起观察到的超氧阴离子自由基和还原型谷胱甘肽以及住院治疗期间的NT - pBNP可能是ST段演变的预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/4c9169d547d2/jpm-13-01050-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/603a38f3b606/jpm-13-01050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/6cc35a96a94b/jpm-13-01050-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/55dc8fe19ff4/jpm-13-01050-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/a6b088b06e5b/jpm-13-01050-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/b5dc8c223f54/jpm-13-01050-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/c81af995b60b/jpm-13-01050-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/18e9dfd77b51/jpm-13-01050-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/5cf581a082df/jpm-13-01050-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/4c9169d547d2/jpm-13-01050-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/603a38f3b606/jpm-13-01050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/6cc35a96a94b/jpm-13-01050-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/55dc8fe19ff4/jpm-13-01050-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/a6b088b06e5b/jpm-13-01050-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/b5dc8c223f54/jpm-13-01050-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/c81af995b60b/jpm-13-01050-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/18e9dfd77b51/jpm-13-01050-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/5cf581a082df/jpm-13-01050-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b576/10381258/4c9169d547d2/jpm-13-01050-g009.jpg

相似文献

1
Prognostic Value of Redox Status Biomarkers in Patients Presenting with STEMI or Non-STEMI: A Prospective Case-Control Clinical Study.氧化还原状态生物标志物在ST段抬高型心肌梗死或非ST段抬高型心肌梗死患者中的预后价值:一项前瞻性病例对照临床研究
J Pers Med. 2023 Jun 26;13(7):1050. doi: 10.3390/jpm13071050.
2
Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.急性冠状动脉综合征中的炎症标志物与心功能:ST 段抬高型心肌梗死(STEMI)与非 STEMI 模型的差异。
Biomed Pharmacother. 2009 Dec;63(10):773-80. doi: 10.1016/j.biopha.2009.06.004. Epub 2009 Oct 13.
3
Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.经皮冠状动脉介入治疗急性冠状动脉综合征中 N 末端脑利钠肽前体的动态变化:缺血负荷、再灌注和结局的标志物。
Clin Chem Lab Med. 2010 Jun;48(6):875-81. doi: 10.1515/CCLM.2010.164.
4
Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.东京都地区ST段抬高型和非ST段抬高型心肌梗死的当前特征与管理:来自东京CCU网络注册队列研究
Heart Vessels. 2016 Nov;31(11):1740-1751. doi: 10.1007/s00380-015-0791-9. Epub 2016 Jan 12.
5
Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015.急性心肌梗死:FAST-MI 项目(1995 年至 2015 年法国急性 ST 段抬高或非 ST 段抬高心肌梗死注册研究)20 年来患者特征、治疗方法的变化和 6 个月预后
Circulation. 2017 Nov 14;136(20):1908-1919. doi: 10.1161/CIRCULATIONAHA.117.030798. Epub 2017 Aug 27.
6
Sex-Based Differences in Presentation, Treatment, and Complications Among Older Adults Hospitalized for Acute Myocardial Infarction: The SILVER-AMI Study.急性心肌梗死住院老年患者在临床表现、治疗及并发症方面的性别差异:SILVER-AMI研究
Circ Cardiovasc Qual Outcomes. 2019 Oct;12(10):e005691. doi: 10.1161/CIRCOUTCOMES.119.005691. Epub 2019 Oct 14.
7
Early- and late-term clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction.ST 段抬高型心肌梗死和非 ST 段抬高型心肌梗死患者的早期和晚期临床结局及其预测因素。
Int J Cardiol. 2013 Nov 15;169(4):254-61. doi: 10.1016/j.ijcard.2013.08.132. Epub 2013 Sep 8.
8
Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction.ST 段抬高型和非 ST 段抬高型心肌梗死患者生物标志物浓度差异及其对长期预后的预测。
Clin Biochem. 2021 Dec;98:17-23. doi: 10.1016/j.clinbiochem.2021.09.001. Epub 2021 Sep 5.
9
New insights in the pathophysiology of acute myocardial infarction detectable by a contemporary troponin assay.通过当代肌钙蛋白检测可发现急性心肌梗死的病理生理学新见解。
Clin Biochem. 2013 Aug;46(12):999-1006. doi: 10.1016/j.clinbiochem.2013.03.026. Epub 2013 Apr 9.
10
Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.心脏型脂肪酸结合蛋白——急性非持续性ST段抬高型冠脉综合征异质性患者群体中心肌坏死的可靠标志物。
Kardiol Pol. 2008 Mar;66(3):253-9, discussion 260-1.

本文引用的文献

1
Increased plasma glutamate in non-smokers with vasospastic angina pectoris is associated with plasma cystine and antioxidant capacity.不吸烟的伴有血管痉挛性心绞痛患者的血浆谷氨酸升高与血浆胱氨酸和抗氧化能力有关。
Scand Cardiovasc J. 2022 Dec;56(1):180-186. doi: 10.1080/14017431.2022.2085884.
2
Oxidants and antioxidants in myocardial infarction (MI): Investigation of ischemia modified albumin, malondialdehyde, superoxide dismutase and catalase in individuals diagnosed with ST elevated myocardial infarction (STEMI) and non-STEMI (NSTEMI).心肌梗死(MI)中的氧化剂与抗氧化剂:对诊断为ST段抬高型心肌梗死(STEMI)和非ST段抬高型心肌梗死(NSTEMI)的个体进行缺血修饰白蛋白、丙二醛、超氧化物歧化酶和过氧化氢酶的研究。
J Med Biochem. 2021 Jun 5;40(3):286-294. doi: 10.5937/jomb0-28879.
3
Trends in ST-elevation myocardial infarction.ST 段抬高型心肌梗死的趋势。
Coron Artery Dis. 2022 Jan 1;31(1):1-8. doi: 10.1097/MCA.0000000000001058.
4
Oxidative stress and its association with ST resolution and clinical outcome measures in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention.氧化应激及其与接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死(STEMI)患者ST段恢复及临床结局指标的关联。
BMC Res Notes. 2020 Nov 11;13(1):525. doi: 10.1186/s13104-020-05350-5.
5
Oxidative Stress Biomarkers, Nut-Related Antioxidants, and Cardiovascular Disease.氧化应激生物标志物、营养相关抗氧化剂与心血管疾病。
Nutrients. 2020 Mar 3;12(3):682. doi: 10.3390/nu12030682.
6
Defining and managing patients with non-ST-elevation myocardial infarction: Sorting through type 1 vs other types.定义和管理非 ST 段抬高型心肌梗死患者:区分 1 型与其他类型。
Clin Cardiol. 2020 Mar;43(3):242-250. doi: 10.1002/clc.23308. Epub 2020 Jan 10.
7
Emerging Biomarkers of Oxidative Stress in Acute and Stable Coronary Artery Disease: Levels and Determinants.急性和稳定型冠状动脉疾病中氧化应激的新兴生物标志物:水平及决定因素
Antioxidants (Basel). 2019 May 1;8(5):115. doi: 10.3390/antiox8050115.
8
ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction: Medical and Surgical Interventions.ST段抬高型心肌梗死与非ST段抬高型心肌梗死:药物及手术干预措施
Crit Care Nurs Clin North Am. 2019 Mar;31(1):49-64. doi: 10.1016/j.cnc.2018.10.002. Epub 2018 Dec 21.
9
Impaired Oxidative Status Is Strongly Associated with Cardiovascular Risk Factors.氧化状态受损与心血管危险因素密切相关。
Oxid Med Cell Longev. 2017;2017:6480145. doi: 10.1155/2017/6480145. Epub 2017 Dec 12.
10
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).2017年欧洲心脏病学会(ESC)ST段抬高型急性心肌梗死患者管理指南:欧洲心脏病学会(ESC)ST段抬高型急性心肌梗死患者管理工作组
Eur Heart J. 2018 Jan 7;39(2):119-177. doi: 10.1093/eurheartj/ehx393.